Subtle‐but‐smouldering myocardial injury after immune checkpoint inhibitor treatment accompanied by amyloid deposits
Abstract Although cardiac troponin is a highly specific biomarker for myocardial cell injury, it is important to recognize the pitfalls of this test in the diagnosis and management of immune checkpoint inhibitor (ICI) myocarditis. We describe the challenging case of an 81‐year‐old woman with persist...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.13915 |
_version_ | 1811288977955618816 |
---|---|
author | Mizuki Ida Shiro Nakamori Shinya Yamamoto Seimi Watanabe Kyoko Imanaka‐Yoshida Masaki Ishida Hajime Sakuma Keiichi Yamanaka Kaoru Dohi |
author_facet | Mizuki Ida Shiro Nakamori Shinya Yamamoto Seimi Watanabe Kyoko Imanaka‐Yoshida Masaki Ishida Hajime Sakuma Keiichi Yamanaka Kaoru Dohi |
author_sort | Mizuki Ida |
collection | DOAJ |
description | Abstract Although cardiac troponin is a highly specific biomarker for myocardial cell injury, it is important to recognize the pitfalls of this test in the diagnosis and management of immune checkpoint inhibitor (ICI) myocarditis. We describe the challenging case of an 81‐year‐old woman with persistently high troponin after undergoing immunotherapy with ipilimumab and nivolumab, and histological evidence of amyloid deposition in the myocardium. The patient received immunosuppressive treatments based on the magnitude of troponin changes because myocarditis was clinically suspected. However, histological examination revealed the deposition of transthyretin amyloid fibrils with only minimal T‐lymphocyte infiltration and no myocyte necrosis, suggesting transthyretin cardiac amyloidosis rather than ICI myocarditis. This case highlights the importance of assessing other causes of persistently high troponin, and the necessity of incorporating comprehensive histological and immunohistochemical examinations of the endomyocardial biopsy, especially when cardiovascular magnetic resonance imaging is inconclusive. |
first_indexed | 2024-04-13T03:46:42Z |
format | Article |
id | doaj.art-3a935b9ef6bd4657b257e483da4571ef |
institution | Directory Open Access Journal |
issn | 2055-5822 |
language | English |
last_indexed | 2024-04-13T03:46:42Z |
publishDate | 2022-06-01 |
publisher | Wiley |
record_format | Article |
series | ESC Heart Failure |
spelling | doaj.art-3a935b9ef6bd4657b257e483da4571ef2022-12-22T03:03:59ZengWileyESC Heart Failure2055-58222022-06-01932027203110.1002/ehf2.13915Subtle‐but‐smouldering myocardial injury after immune checkpoint inhibitor treatment accompanied by amyloid depositsMizuki Ida0Shiro Nakamori1Shinya Yamamoto2Seimi Watanabe3Kyoko Imanaka‐Yoshida4Masaki Ishida5Hajime Sakuma6Keiichi Yamanaka7Kaoru Dohi8Department of Cardiology and Nephrology Mie University Graduate School of Medicine 174 Edobashi Tsu Mie 5148507 JapanDepartment of Cardiology and Nephrology Mie University Graduate School of Medicine 174 Edobashi Tsu Mie 5148507 JapanDepartment of Dermatology Mie University Graduate School of Medicine Tsu JapanDepartment of Dermatology Mie University Graduate School of Medicine Tsu JapanDepartment of Pathology Mie University Graduate School of Medicine Tsu JapanDepartment of Radiology Mie University Graduate School of Medicine Tsu JapanDepartment of Radiology Mie University Graduate School of Medicine Tsu JapanDepartment of Dermatology Mie University Graduate School of Medicine Tsu JapanDepartment of Cardiology and Nephrology Mie University Graduate School of Medicine 174 Edobashi Tsu Mie 5148507 JapanAbstract Although cardiac troponin is a highly specific biomarker for myocardial cell injury, it is important to recognize the pitfalls of this test in the diagnosis and management of immune checkpoint inhibitor (ICI) myocarditis. We describe the challenging case of an 81‐year‐old woman with persistently high troponin after undergoing immunotherapy with ipilimumab and nivolumab, and histological evidence of amyloid deposition in the myocardium. The patient received immunosuppressive treatments based on the magnitude of troponin changes because myocarditis was clinically suspected. However, histological examination revealed the deposition of transthyretin amyloid fibrils with only minimal T‐lymphocyte infiltration and no myocyte necrosis, suggesting transthyretin cardiac amyloidosis rather than ICI myocarditis. This case highlights the importance of assessing other causes of persistently high troponin, and the necessity of incorporating comprehensive histological and immunohistochemical examinations of the endomyocardial biopsy, especially when cardiovascular magnetic resonance imaging is inconclusive.https://doi.org/10.1002/ehf2.13915AmyloidCardiovascular magnetic resonance imagingEndomyocardial biopsyImmune checkpoint inhibitorImmunosuppressive therapyMyocarditis |
spellingShingle | Mizuki Ida Shiro Nakamori Shinya Yamamoto Seimi Watanabe Kyoko Imanaka‐Yoshida Masaki Ishida Hajime Sakuma Keiichi Yamanaka Kaoru Dohi Subtle‐but‐smouldering myocardial injury after immune checkpoint inhibitor treatment accompanied by amyloid deposits ESC Heart Failure Amyloid Cardiovascular magnetic resonance imaging Endomyocardial biopsy Immune checkpoint inhibitor Immunosuppressive therapy Myocarditis |
title | Subtle‐but‐smouldering myocardial injury after immune checkpoint inhibitor treatment accompanied by amyloid deposits |
title_full | Subtle‐but‐smouldering myocardial injury after immune checkpoint inhibitor treatment accompanied by amyloid deposits |
title_fullStr | Subtle‐but‐smouldering myocardial injury after immune checkpoint inhibitor treatment accompanied by amyloid deposits |
title_full_unstemmed | Subtle‐but‐smouldering myocardial injury after immune checkpoint inhibitor treatment accompanied by amyloid deposits |
title_short | Subtle‐but‐smouldering myocardial injury after immune checkpoint inhibitor treatment accompanied by amyloid deposits |
title_sort | subtle but smouldering myocardial injury after immune checkpoint inhibitor treatment accompanied by amyloid deposits |
topic | Amyloid Cardiovascular magnetic resonance imaging Endomyocardial biopsy Immune checkpoint inhibitor Immunosuppressive therapy Myocarditis |
url | https://doi.org/10.1002/ehf2.13915 |
work_keys_str_mv | AT mizukiida subtlebutsmoulderingmyocardialinjuryafterimmunecheckpointinhibitortreatmentaccompaniedbyamyloiddeposits AT shironakamori subtlebutsmoulderingmyocardialinjuryafterimmunecheckpointinhibitortreatmentaccompaniedbyamyloiddeposits AT shinyayamamoto subtlebutsmoulderingmyocardialinjuryafterimmunecheckpointinhibitortreatmentaccompaniedbyamyloiddeposits AT seimiwatanabe subtlebutsmoulderingmyocardialinjuryafterimmunecheckpointinhibitortreatmentaccompaniedbyamyloiddeposits AT kyokoimanakayoshida subtlebutsmoulderingmyocardialinjuryafterimmunecheckpointinhibitortreatmentaccompaniedbyamyloiddeposits AT masakiishida subtlebutsmoulderingmyocardialinjuryafterimmunecheckpointinhibitortreatmentaccompaniedbyamyloiddeposits AT hajimesakuma subtlebutsmoulderingmyocardialinjuryafterimmunecheckpointinhibitortreatmentaccompaniedbyamyloiddeposits AT keiichiyamanaka subtlebutsmoulderingmyocardialinjuryafterimmunecheckpointinhibitortreatmentaccompaniedbyamyloiddeposits AT kaorudohi subtlebutsmoulderingmyocardialinjuryafterimmunecheckpointinhibitortreatmentaccompaniedbyamyloiddeposits |